Credits Available: 4.25 AMA PRA Category 1 Credit™/ MOC Points

Description: This dynamic course focuses on the exchange of best practices regarding the use of bispecifics in patients with R/R DLBCL including patient eligibility. Through this interactive, small-group activity, participants will review brief modules and patient cases to identify signs and symptoms of toxicities experienced while receiving treatment with bispecific antibodies for R/R DLBCL and also integrate protocols to manage CRS and ICANS effectively when managing patients. The group will gather for a live discussion via Zoom to share and exchange ideas on this topic.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Pharmacist, Physician Assistant
Target Specialties: Hematology, Hematology/Oncology, Oncology

Cole Sterling

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Assistant Professor of Oncology

Hello! I am originally from Huntsville, AL and moved to Baltimore for medical school at Johns Hopkins in 2013. I since completed my education and training in internal medicine and oncology at Johns Hopkins before transitioning to faculty in 2022. As an Assistant Professor in the Division of Hematologic Malignancies, I specialize in lymphoma, CLL, and bone marrow transplantation. In addition to my role as a clinical investigator, I am passionate about clinical medicine and teaching. My goal is to make this educational initiative practical, helpful, informative, and fun (or at least as painless as possible :) I look forward to working with you all!